Table 5 Demographic characteristics of the participants
Variable | Group 1 2,500 PfSPZ in 10 µL IM N = 6 Median (Min; max) | Group 2 2,500 PfSPZ in 50 µL IM N = 6 Median (Min; max) | Group 3 2,500 PfSPZ in 250 µL IM N = 6 Median (Min; max) | Group 4 3,200 PfSPZ in 500 µL DVI N = 6 Median (Min; max) | Group 5 25,000 PfSPZ in 10 µL IM N = 6 Median (Min; max) | Group 6 75,000 PfSPZ in 10 µL IM N = 6 Median (Min; max) | Total N = 36 Median (Min; max) |
|---|---|---|---|---|---|---|---|
Age (years) | 33 | 26 | 30 | 29 | 22 | 25 | 26 |
(21; 41) | (21; 32) | (24; 35) | (19; 40) | (20; 25) | (20; 32) | (19; 41) | |
Weight (Kg) | 63 | 67 | 80 | 61 | 60 | 54 | 63 |
(58; 86) | (51; 79) | (58; 93) | (54; 73) | (51; 70) | (52; 79) | (51; 93) | |
Height (m) | 1.71 | 1.71 | 1.74 | 1.69 | 1.7 | 1.64 | 1.7 |
(1.68; 1.75) | (1.65; 1.86) | (1.63; 1.85) | (1.59; 1.72) | (1.56; 1.75) | (1.60; 1.84) | (1.56; 1.86) | |
BMI (kg/m2) | 22 | 21.5 | 26.2 | 22.8 | 21.3 | 20.3 | 22 |
(20.1; 28.1) | (18.0; 25.8) | (21.9; 30.7) | (19.1; 24.8) | (19.9; 22.8) | (19.4; 23.5) | (18.0; 30.7) | |
Sex | |||||||
Female | 2 (33%) | 3 (50%) | 1 (17%) | 4 (67%) | 5 (83%) | 5 (83%) | 20 (56%) |
Male | 4 (67%) | 3 (50%) | 5 (83%) | 2 (33%) | 1 (17%) | 1 (17%) | 16 (44%) |